For citations:
Lapina N.V., Stosman K.I., Melikhova M.V., Vakunenkova O.A., Batotsyrenova E.G., Kashuro V.A., Rozhko M.A. Preclinical toxicology of alofanib, an allosteric inhibitor of fibroblast growth factor receptor 2. Malignant tumours. 2019;9(3):65-70. (In Russ.) https://doi.org/10.18027/2224-5057-2019-9-3-65-70
Email this article 